(Q33366403)

English

Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma

scientific article

Statements

Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma (English)
Dorothea Kofahl-Krause
Ulrich von Grünhagen

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit